Meridian Bioscience/ US5895841014 /
| 2023-01-30 9:59:52 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 33.98USD | - | 112,605 Turnover: 3.83 mill. |
-Bid Size: - | -Ask Size: - | 1.5 bill.USD | - | 35.02 |
Assets
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 30.4500 | 30.5100 | 29.9950 | 30.5670 | 31.1200 | ||||||
| Intangible Assets | 29.8550 | 26.7040 | 23.1130 | 60.2430 | 83.1970 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 125.0320 | 115.9020 | 112.3240 | 180.7170 | 243.0710 | ||||||
| Inventories | 45.0570 | 41.4930 | 41.9930 | 39.6170 | 61.2640 | ||||||
| Accounts Receivable | 27.1020 | 29.1060 | 32.3360 | 35.6080 | 38.5120 | ||||||
| Cash and Cash Equivalents | 47.2260 | 57.0720 | 59.7630 | 62.3970 | 53.5140 | ||||||
| Current Assets | 126.7910 | 133.8750 | 139.0530 | 144.7610 | 162.1900 | ||||||
| Total Assets | 251.8230 | 249.7770 | 251.3770 | 325.4780 | 405.2610 | ||||||
Liabilities
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 7.6270 | 7.7190 | 6.2600 | 7.2380 | 11.9690 | ||||||
| Long-term debt | 54.6100 | 50.1470 | 44.9300 | 75.8240 | 68.8240 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 2.8000 | 4.5000 | 3.8000 | 2.5000 | 3.8000 | ||||||
| Liabilities | 85.3510 | 80.1920 | 75.9590 | 134.5110 | 157.6320 | ||||||
| Share Capital | - | - | - | - | - | ||||||
| Total Equity | 166.4720 | 169.5850 | 175.4180 | 190.9670 | 247.6290 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 251.8230 | 249.7770 | 251.3770 | 325.4780 | 405.2610 | ||||||
Income Statement
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 196.0820 | 200.7710 | 213.5710 | 201.0140 | 253.6670 | ||||||
| Depreciation (total) | 6.6270 | 8.1180 | 7.9240 | 9.9640 | 13.5670 | ||||||
| Operating Result | 51.3780 | 37.3820 | 31.5840 | 32.6990 | 61.3240 | ||||||
| Interest Income | -.8300 | -1.4710 | -1.1020 | -1.2640 | -2.4900 | ||||||
| Income Before Taxes | 50.6440 | 36.4290 | 30.3800 | 31.5570 | 59.2930 | ||||||
| Income Taxes | 18.4150 | 14.8720 | 6.5310 | 7.1750 | 13.1070 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 32.2290 | 21.5570 | 23.8490 | 24.3820 | 46.1860 | ||||||
Per Share
Cash Flow
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 37.2230 | 41.3550 | 34.7830 | 35.8310 | 47.9760 | ||||||
| Cash Flow from Investing Activities | -66.6950 | -4.4670 | -4.2010 | -48.4520 | -54.5980 | ||||||
| Cash Flow from Financing | 27.2050 | -27.7130 | -27.5930 | 15.2600 | -3.5570 | ||||||
| Decrease / Increase in Cash | -2.7470 | 9.8460 | 2.6910 | 1.6340 | -8.8830 | ||||||
| Employees | 650 | 420 | 400 | 485 | 560 | ||||||
